
5.04BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US12477X1063
CUSIP
12477X106
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
10.59
PEG Ratio
-
Book Value
2.23
Dividend Share
-
Dividend Yield
-
Earnings Share
1.66
Wall Street Target Price
34.23
EPS Estimate Current Year
0.11
EPS Estimate Next Year
0.27
EPS Estimate Current Quarter
0.0201
EPS Estimate Next Quarter
0.1122
Most Recent Quarter
-
Revenue TTM
1,048,129,024
Gross Profit TTM
726,014,016
EBITDA
162,435,008
Profit Margin
9.17%
Return On Assets TTM
7.81%
Return On Equity TTM
17.19%
Revenue Per Share TTM
3.701
Qtly Revenue Growth YOY
27.00%
Diluted Eps TTM
1.66
Qtly Earnings Growth YOY
-37.50%
Trailing PE
10.59
Forward PE
24
Price Sales TTM
4.8102
Price Book MRQ
7.8997
Enterprise Value Revenue
4
Enterprise Value EBITDA
29
965.00
0.00%128.26
0.00%390.94
-2.36%151.52
-2.31%925.70
-1.93%32.39
-1.88%318.32
-1.17%516.11
-1.04%917.00
-0.91%199.30
-0.11%